Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829204 · ClinicalTrials.gov registry record
Prospective Data Bank Creation to Study Vaginal Conditions
A clinical trial of Bacterial Vaginosis and Vulvodynia, sponsored by Texas Tech University Health Sciences Center.
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT01829204: Recruiting study of Bacterial Vaginosis and Vulvodynia, sponsored by Texas Tech University Health Sciences Center.
NCT01829204 is a study of Bacterial Vaginosis and Vulvodynia that is actively recruiting participants, run by Texas Tech University Health Sciences Center. The registered enrollment target is 550 participants, above the 302-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01829204, a study of Bacterial Vaginosis and Vulvodynia, is actively recruiting participants, sponsored by Texas Tech University Health Sciences Center.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and elucidate the pattern and perhaps role of atypical proteins, cytokines and vaginal microbial flora in the pathogenic mechanisms involved in the development of vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor.
Primary Outcome
To determine types of cytokines normally present in women's vagina and in patients with vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor
Conditions Studied
Study Locations (1)
Texas
- TTUHSC Permian Basin - Midland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2013-04 |
| Est. Completion | 2027-12 |
What NCT01829204 shows while recruiting
NCT01829204 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, above the 302-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (82% higher).
The record links to 4 conditions, with Bacterial Vaginosis appearing as the primary indexed condition, and to 0 interventions.
NCT01829204 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01829204 about?
NCT01829204 is a clinical study titled "Prospective Data Bank Creation to Study Vaginal Conditions". The purpose of this study is to identify and elucidate the pattern and perhaps role of atypical proteins, cytokines and vaginal microbial flora in the pathogenic mechanisms involved in the development of vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor.
What is the current status of trial NCT01829204?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2013-04. Estimated completion is 2027-12.
What conditions does trial NCT01829204 study?
This clinical trial studies the following conditions: Bacterial Vaginosis, Vulvodynia, Preterm Labor, Mycoses.
Who is sponsoring clinical trial NCT01829204?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01829204 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Vaginosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01829204's enrollment target sits among peer trials
550 5th of 15 higher than 11 of 15 other Bacterial Vaginosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacterial Vaginosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Protocol CERN Feasibility Study
RECRUITING · NA
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
RECRUITING · Early Phase 1
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
COMPLETED · Phase 4
-
Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis
COMPLETED
-
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia